These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28864659)

  • 1. A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.
    Williams B; Correnti J; Oranu A; Lin A; Scott V; Annoh M; Beck J; Furth E; Mitchell V; Senkal CE; Obeid L; Carr RM
    FASEB J; 2018 Jan; 32(1):130-142. PubMed ID: 28864659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
    Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
    Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice.
    Carr RM; Peralta G; Yin X; Ahima RS
    PLoS One; 2014; 9(5):e97118. PubMed ID: 24831094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
    Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
    Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6.
    Kim MH; Ahn HK; Lee EJ; Kim SJ; Kim YR; Park JW; Park WJ
    Int J Mol Med; 2017 Feb; 39(2):453-462. PubMed ID: 28035360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells.
    Correnti JM; Gottshall L; Lin A; Williams B; Oranu A; Beck J; Chen J; Bennett MJ; Carr RM
    Sci Rep; 2018 Aug; 8(1):12923. PubMed ID: 30150688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome.
    Libby AE; Bales E; Orlicky DJ; McManaman JL
    J Biol Chem; 2016 Nov; 291(46):24231-24246. PubMed ID: 27679530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression.
    Jin Y; Tan Y; Chen L; Liu Y; Ren Z
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice.
    Correnti J; Lin C; Brettschneider J; Kuriakose A; Jeon S; Scorletti E; Oranu A; McIver-Jenkins D; Kaneza I; Buyco D; Saiman Y; Furth EE; Argemi J; Bataller R; Holland WL; Carr RM
    J Lipid Res; 2020 Jul; 61(7):983-994. PubMed ID: 32398264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcoholic Setdb1 suppression promotes hepatosteatosis in mice by strengthening Plin2.
    Zhang Y; Li Y; Liu Y; Wang H; Chen Y; Zhang B; Song M; Song L; Ding Q; Qiu J; Fan M; Qu L; Wang Z
    Metabolism; 2023 Sep; 146():155656. PubMed ID: 37419179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A missense variant in human perilipin 2 (
    Scorletti E; Saiman Y; Jeon S; Schneider CV; Buyco DG; Lin C; Himes BE; Mesaros CA; Vujkovic M; Creasy KT; Furth EE; Billheimer JT; Hand NJ; Kaplan DE; Chang KM; Tsao PS; Lynch JA; Dempsey JL; Harkin J; Bayen S; Conlon D; Guerraty M; Phillips MC; Rader DJ; Carr RM
    JHEP Rep; 2024 Jan; 6(1):100902. PubMed ID: 38074507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcoholic and non-alcoholic fatty liver disease: Focus on ceramide.
    Nikolova-Karakashian M
    Adv Biol Regul; 2018 Dec; 70():40-50. PubMed ID: 30455063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
    Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
    Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.
    Imai Y; Boyle S; Varela GM; Caron E; Yin X; Dhir R; Dhir R; Graham MJ; Ahima RS
    Physiol Genomics; 2012 Nov; 44(22):1125-31. PubMed ID: 23012396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
    Turpin SM; Nicholls HT; Willmes DM; Mourier A; Brodesser S; Wunderlich CM; Mauer J; Xu E; Hammerschmidt P; Brönneke HS; Trifunovic A; LoSasso G; Wunderlich FT; Kornfeld JW; Blüher M; Krönke M; Brüning JC
    Cell Metab; 2014 Oct; 20(4):678-86. PubMed ID: 25295788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
    Sen NE; Arsovic A; Meierhofer D; Brodesser S; Oberschmidt C; Canet-Pons J; Kaya ZE; Halbach MV; Gispert S; Sandhoff K; Auburger G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice.
    Liangpunsakul S; Rahmini Y; Ross RA; Zhao Z; Xu Y; Crabb DW
    Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G515-23. PubMed ID: 22194417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Action of Autophagy and Adipose Tissue Triglyceride Lipase Ameliorates Diet-Induced Hepatic Steatosis in Liver-Specific PLIN2 Knockout Mice.
    Griffin JD; Bejarano E; Wang XD; Greenberg AS
    Cells; 2021 Apr; 10(5):. PubMed ID: 33923083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.